Skip to main content

Research Repository

Advanced Search

Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy

Kargaran, Parisa K.; Evans, Jared M.; Bodbin, Sara E.; Smith, James G. W.; Nelson, Timothy J.; Denning, Chris; Mosqueira, Diogo

Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy Thumbnail


Authors

Parisa K. Kargaran

Jared M. Evans

Sara E. Bodbin

James G. W. Smith

Timothy J. Nelson

CHRIS DENNING chris.denning@nottingham.ac.uk
Professor of Stem Cell Biology

Diogo Mosqueira



Abstract

Hypertrophic cardiomyopathy (HCM) is a prevalent and untreatable cardiovascular disease with a highly complex clinical and genetic causation. HCM patients bearing similar sarcomeric mutations display variable clinical outcomes, implying the involvement of gene modifiers that regulate disease progression. As individuals exhibiting mutations in mitochondrial DNA (mtDNA) present cardiac phenotypes, the mitochondrial genome is a promising candidate to harbor gene modifiers of HCM. Herein, we sequenced the mtDNA of isogenic pluripotent stem cell-cardiomyocyte models of HCM focusing on two sarcomeric mutations. This approach was extended to unrelated patient families totaling 52 cell lines. By correlating cellular and clinical phenotypes with mtDNA sequencing, potentially HCM-protective or -aggravator mtDNA variants were identified. These novel mutations were mostly located in the non-coding control region of the mtDNA and did not overlap with those of other mitochondrial diseases. Analysis of unrelated patients highlighted family-specific mtDNA variants, while others were common in particular population haplogroups. Further validation of mtDNA variants as gene modifiers is warranted but limited by the technically challenging methods of editing the mitochondrial genome. Future molecular characterization of these mtDNA variants in the context of HCM may identify novel treatments and facilitate genetic screening in cardiomyopathy patients towards more efficient treatment options.

Citation

Kargaran, P. K., Evans, J. M., Bodbin, S. E., Smith, J. G. W., Nelson, T. J., Denning, C., & Mosqueira, D. (2020). Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy. Journal of Clinical Medicine, 9(8), Article 2349. https://doi.org/10.3390/jcm9082349

Journal Article Type Article
Acceptance Date Jul 21, 2020
Online Publication Date Jul 23, 2020
Publication Date 2020-08
Deposit Date Jul 27, 2020
Publicly Available Date Jul 27, 2020
Journal Journal of Clinical Medicine
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 9
Issue 8
Article Number 2349
DOI https://doi.org/10.3390/jcm9082349
Public URL https://nottingham-repository.worktribe.com/output/4785923
Publisher URL https://www.mdpi.com/2077-0383/9/8/2349